PHASE I, IN VIVO AND IN VITRO PHARMACOLOGY OF A CHEMOPREVENTIVE AGENT -261025120

$0N01FY2002CANIH

Fox Chase Cancer Center (Inc),

Investigators

View original record on NIH RePORTER →